United States: ACA Cost-Sharing Reductions– A Momentary Reprieve And Ongoing Doubts

The Future of CSRs – A Tale Told in Tweets. In follow-up to our May 5, 2017 blog post, " ACA Cost-Sharing Reductions: An Uncertain Future," on August 16, 2017, the Trump Administration made an announcement (Announcement) that it will continue to fund cost-sharing reduction (CSR) payments to insurers in accordance with the CSR provisions in the Affordable Care Act (ACA) for the month of August. The Announcement did not include any commitments to fund CSR payments in September or anytime thereafter.

Although stakeholders in the CSR debate – including healthcare insurance companies (Payors) that participate in the ACA exchanges and insureds who obtain health insurance coverage through the exchanges – gladly accepted the one-month reprieve from the threat of CSR de-funding, anxiety continues and will continue until the Trump Administration reveals its long-term policy regarding future funding of CSR payments on an ongoing basis.

While gazing into their crystal balls to assess the future of CSR payments, armchair pundits and their professional counterparts need to consider President Trump's prior statements, stump speeches, and tweets that show his general disdain for the ACA and, more specifically, the ACA's CSR payment provisions. In a July 29, 2017 tweet, President Trump wrote, "If a new HealthCare Bill is not approved quickly, BAILOUTS for Insurance Companies and BAILOUTS for Members of Congress will end very soon!"

The Congressional Budget Office's Perspective. Given the timing of the Announcement – one day after the August 15, 2017 issuance of a Congressional Budget Office (CBO) and Joint Committee on Taxation (JCT) report (available here) (CBO Report) on the potential impact of defunding the CSR payment program – the Announcement's publication caused significant reverberations amongst CSR stakeholders, news organizations that report on healthcare, and those who follow the ups-and-downs of the ACA debate.

In order to understand the Announcement's reception and potential impacts on the U.S. healthcare system, a review of the CBO Report is essential.

CSRs – The What's, Why's and Wherefores. Under the ACA, Payors that participate in the ACA exchanges are required to offer four categories of health plans identified by metals – Platinum, Gold, Silver and Bronze. In the broadest of terms, each category of plan is differentiated by premium costs, coverage requirements, and other factors that make Platinum plans more desirable than Gold, Gold more desirable than Silver, and Silver more desirable than Bronze. For example, of the four healthcare plan categories, Platinum plans provide their members with the highest monthly premiums, the broadest scope of coverage, and the lowest patient financial responsibility (copays and deductibles) amounts as compared to the premiums/coverage/patient financial responsibility amounts provided to Gold, Silver, and Bronze plan members. By corollary, it will come as no surprise that Bronze plans offer their members the lowest premiums, the least amount of coverage, and the highest patient financial responsibility amounts, than are offered to Premium, Gold, and Silver plan members.

Out of a concern that people seeking healthcare coverage on the exchanges would flock to the Bronze plans as the least expensive way to avoid the federal penalties for not having health coverage, the ACA includes provisions designed to entice people away from the comparatively poor coverage offered by Bronze plans and to the better coverage offered by Silver plans. To steer people away from the Bronze plans, the ACA requires that Payors offer discounted deductibles, copayments and coinsurance requirements to Silver plan enrollees who are eligible to receive such discounts under the ACA. The discounts – which are collectively defined as cost-sharing reductions (CSRs) – are designed to reduce the overall cost of healthcare for those Silver plan individual and family members whose income is at or below 250% of the Federal Poverty Limit (FPL) as set forth in the Federal Poverty Guidelines for the then-current federal fiscal year.

To insulate exchange-participating Payors from the costs of providing CSRs to Silver plan members – and to prevent such Payors from passing its CSR-related costs onto other members of other plans by raising premiums – the ACA obligates the federal government to reimburse Payors for the CSR-related costs incurred under their Silver plans.

In short, the CSRs are intended to (i) lower overall healthcare costs for qualified low income individuals and families who choose to enroll in a Silver plan; and (ii) increase the overall level and quality of coverage provided to the total population of insureds who access coverage through the ACA exchanges or elsewhere.

CSRs – An Illegal Subsidy? As has been widely publicized over the years, Republicans have generally opposed every aspect of the Affordable Care Act, including CSRs. To that end, the House of Representatives sued in 2014 to stop the federal government from making CSR payments to Payors participating on the exchanges. According to the House's complaint, the CSR payments are illegal because the ACA does not include any specific Congressional appropriation to fund the payments. Although the House prevailed at the federal district court level, the presiding judge stayed the decision pending the conclusion of the appeals process. As a result and as of this writing, the ACA's CSR payment provisions remain in effect.

The Stresses and Strains of CSR Uncertainty. As noted at the outset of this writing, although the President has signaled his disdain for CSR payments as an illegal giveaway to the insurance industry, the Administration has allowed CSR payments to limp along from one month to the next without providing any clarity as to the long-term prospects of future CSR payments in the short-term or the long-term.

As would be expected, the uncertainty around the future of CSR payments has created anxiety for Payors. If CSR payments are terminated during the remaining months of this calendar year, the Payors will be stuck bearing the extra costs of providing CSR benefits to their Silver plan enrollees for the rest of 2017 without receiving any reimbursement from the federal government to offset such costs. This would likely be tremendous burden on the Payors since each of them set their 2017 premiums without considering the overwhelming expense of providing CSR discounts without the financial assistance provided by CSR payments.

Further, Payors that participate in the ACA exchanges are required to file rates with state regulators for calendar year 2018 plans by September 6, 2017. Without any definitive CSR guidance in the offing, Payors are flying blind as to their anticipated 2018 expenses and, in turn, the 2018 rates that would need to be set to cover their anticipated 2018 expenses. Given the prevailing uncertainty in the Payor rate-setting process, and the larger concern voiced by the CSR stakeholders that uninformed Payors will be forced to set rates higher than they otherwise would have if they had known that CSR payments were going to be available – or not available, or partially available – during the 2018 plan year. Although this problem has yet to be resolved, there is some speculation that state regulators in some states will allow Payors to submit two sets of rates—one set assuming continuation of CSR payments and one set assuming elimination of CSR payments.

It should be noted that the Trump administration is not the only voice in this matter. Congress can pass legislation to specifically appropriate money for the CSR payments at any time. But, of course, President Trump would be required to sign the appropriation bill into law or else Congress would have to override President Trump's veto by a vote of 2/3rds in each of the House of Representatives and the Senate. There has been media speculation that Congress will take this matter up after it returns from recess in early September, though not in time to resolve whether CSR payments will continue prior to the rate submission deadline of September 6, 2017.

Key Takeaways of the Report. The CBO Report compares the anticipated effects of eliminating CSR payments to health insurance companies starting January 1, 2018 compared to what the CBO Report and this blog post refers to as the "baseline"—which is indefinite continuation of CSR payments as presently administered.

Following are the key takeaways in the CBO Report:

  • Effects on Market Stability

The CBO Report speculates that the elimination of CSR payments will lead to uncertainty in the insurance exchange marketplace regarding, among other points, effects on gross enrollments in exchange plans, enrollment mix, and appropriate pricing for plans.

As a result of the uncertainty, according to the CBO Report, Payor participation on the state insurance exchanges will diminish in 2018 and 2019. The CBO Report estimates that in 2018 and 2019, 5% of United States residents will live in areas that will have no insurers offering non-group plans on the insurance exchanges, compared to approximately 0.5% at baseline.

Despite the increase in areas without participating Payors on the health insurance exchanges, there is anticipated to be "sufficient demand for insurance by enough people, including people with low healthcare expenditures, for the markets to be stable in most areas."

By 2020, however, the CBO Report estimates that this problem will be largely mitigated and people "in almost all areas" will have access to health insurance exchange plans.

The CBO Report notes that the timing of when a definitive determination is made known regarding whether federal CSR payments will continue in 2018 vis-ŕ-vis the deadline for plans to submit rates to state insurance regulators for calendar year 2018, which is September 6, 2017, will likely effect participation by the health insurers on the exchanges in 2018.

  • Effects on Health Insurance Coverage

The CBO Report estimates that the elimination of CSR payments will result in an additional 1 million uninsured persons in 2018 compared to the baseline, driven by the anticipated reduction of Payors participating in the state health insurance exchanges in 2018 (as discussed above).

  • Effects on Gross Premiums Charged by Payors

Silver plan premiums that are currently discounted for qualifying enrollees as a result of the CSR payment program will, according to the CBO, increase as Payors take action to neutralize the resulting financial impact from the discontinuation of CSR payments. The CBO Report estimates that Silver plan premiums will rise approximately 20% in 2018 relative to the baseline and "rise slightly more" in later years.

As acknowledged by the CBO, the above estimate assumes that state insurance regulators will allow Payors to increase Silver plan premiums to the degree that the Payors would like in order to neutralize the loss of CSR payments. Given current and widespread concerns regarding the lack of Payor participation on the exchanges, the CBO has predicted that regulators will approve the increases in order to mollify the Payors and hopefully prevent additional Payors from leaving the exchanges.

  • Net Effects on Consumers

Despite the CBO prediction that premiums will increase, the CBO estimates that the cost to consumer for purchasing individual plans (as opposed to group plans) on the health insurance exchanges will remain generally steady compared to baseline. The CBO basis this prediction on the following:

(1) As reasoned by the CBO, enrollees who receive the reduced Silver plan premiums that are supported by the CSR payments (specifically enrollees who have income between 100% to 200% of the FPL) also qualify for tax credits to help offset health insurance premiums. The CBO Report concludes that the tax credits will effectively cancel out the increase in premiums for those persons, resulting in the net cost (after accounting for the tax credit) of premiums for the Silver plans to the persons who qualify for the tax credit to be unchanged; and

(2) If the Silver Plan premium costs increase disproportionately compared to the other metal plans, the CBO anticipates that persons who do not qualify for the tax credit will purchase a different metal category of health plan that hasn't suffered a disproportionate increase in premium rates.

Notwithstanding the above, the CBO Report does not include any commentary on whether higher premium rates that are made lower through tax credits will be as well received by consumers as the consumers received lower/discounted premiums. According to many analysts, there is no reliable equivalency between these two approaches to lowering the out-of-pocket costs for consumers who select Silver Plan coverage.

As noted by the analysts, discounts through tax credits are not realized until the taxpayer files his or tax return and receives a tax refund – well after the higher premium has been paid. By comparison, up-front discounts resulting in lower premiums are realized instantaneous when the consumer pays his or her monthly premiums. Based upon the theory that delayed gratification is no gratification at all, some analysts have raised significant concerns that the tax-credit approach will not drive as many consumers to Silver Plans as the lower Silver Plan premium approach has done.

If the analysts' misgivings regarding the ability of tax credits to sustain or grow Silver plan enrollment are proved to be valid, the CBO's conclusion that the out-of-pocket costs for consumers who access individual coverage on the exchanges will remain steady will not be provided to be invalid.

  • Effects on the Federal Budget

The CBO Report estimates that the cost of the additional tax credits for those enrollees benefiting from the CSRs (which are only available for persons with up to 250% of the FPL) will be roughly equal to the savings for eliminating federal payments of the cost of the CSRs to the health insurer. Nevertheless, federal deficits will rise because a significant number of Silver plan enrollees who were not eligible for the CRO-driven discounts in the past, will be eligible for tax credits. In short, more tax credits means less tax revenue means greater deficits.

Finally, as included in the CBO Report, the CBO believes that the $7 billion increase in federal revenue that was to be realized from increased income tax collections and penalties for employers that do not offer health insurance will not materialize as hoped if the CSR payments are eliminated. According to the CBO Report, the anticipated increase in revenue will be offset by an anticipated net increase of $7 billion in federal expenses that, as described above, will result from the elimination of CSR payments.

The CBO Report includes estimates that federal deficits will increase by $194 billion from 2017 through 2026 (including $6 billion in 2018, $21 billion in 2020 and $26 billion in 2026) as a result of eliminating CSR federal payments to Payors.

Conclusion. Although President Trump and members of his Administration have not been shy about their desires to repeal the Affordable Care Act or, at the very least, cripple it so it will collapse on its own accord, the CBO Report states that the termination of CSR payments may not be the body blow to the ACA that the President intends it to be. In the CBO Report, the CBO conjectures that the temporary negatives of market destabilization (lower enrollment through the exchanges, fewer Payors offering coverage on the exchanges, increases in out-of-pocket costs for enrollees, etc.) as caused by the elimination of CRO payments could, in the long run, yield to lower net costs for consumers and, in turn, a growing number of insureds under the ACA. In this way, the temporary pain caused by the elimination of the CSR payments may, in the long run, result in a stronger ACA.

Time will tell – at the very least on a month-to-month basis.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Events from this Firm
24 Oct 2017, Seminar, Los Angeles, United States

Presented by The American Bar Association White Collar Crime Committee.

24 Oct 2017, Conference, Los Angeles, United States

Corporate transactions are not just in the domain of M&A corporate attorneys. This program will cover the important role of employment and benefits counsel in shaping mergers and acquisitions. The presenters will provide practical guidance on conducting due diligence of labor, employment, employee benefits and executive compensation arrangements of target companies.

25 Oct 2017, Business Breakfast, New York, United States

Please join us for a complimentary breakfast program and networking with private equity investment banking professionals to discuss private equity activity and prospective deal flow opportunities in the technology industry.

 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.